Diode laser treatment for retinopathy of prematurity: structural and functional outcome

C S Ling1, B W Fleck, E Wright

  • 1Princess Alexandra Eye Pavilion, Edinburgh.

Insights

Binocular indirect ophthalmoscope (BIO) diode laser photocoagulation effectively treated retinopathy of prematurity (ROP) in infants. This method achieved favorable anatomical and functional outcomes with reduced complications compared to cryotherapy.

Area of Science:

  • Ophthalmology
  • Neonatal Care

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of childhood blindness.
  • Early detection and treatment are crucial for preserving vision in premature infants.

Purpose of the Study:

  • To evaluate the anatomical and functional outcomes of ROP treatment using binocular indirect ophthalmoscope (BIO) diode laser photocoagulation.
  • To compare the efficacy and morbidity of BIO diode laser treatment with cryotherapy.

Main Methods:

  • A cohort of 13 infants (25 eyes) with threshold ROP received BIO diode laser photocoagulation.
  • Treatment was administered under general anesthesia, with a median of 1200 burns per eye.
  • Infants had a median postmenstrual age of 25.5 weeks at birth and 35 weeks at treatment.

Main Results:

  • Active retinopathy resolved in all but one infant within 1-2 weeks post-treatment.
  • All treated eyes demonstrated favorable anatomical and functional outcomes at a median follow-up of 19.5 months.
  • No significant ocular or systemic complications were observed during the procedure.

Conclusions:

  • BIO diode laser photocoagulation is an effective treatment for retinopathy of prematurity.
  • This treatment modality offers comparable efficacy to cryotherapy with a lower incidence of morbidity.
Abstract